NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Journal
Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
4
9
2020
pubmed:
5
9
2020
medline:
5
11
2021
Statut:
ppublish
Résumé
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.
Identifiants
pubmed: 32886895
doi: 10.6004/jnccn.2020.0043
pii: jnccnGLINS1809
pmc: PMC10191771
mid: NIHMS1895045
doi:
pii:
Types de publication
Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1160-1170Subventions
Organisme : NCI NIH HHS
ID : K12 CA090625
Pays : United States
Références
World J Urol. 2018 Dec;36(12):1891-1898
pubmed: 29680948
Lancet Oncol. 2015 Nov;16(15):1473-1482
pubmed: 26482279
Lancet Oncol. 2009 Dec;10(12):1199-206
pubmed: 19959076
BJU Int. 2016 Feb;117(2):260-5
pubmed: 25307281
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
Cancer. 2000 Aug 1;89(3):604-14
pubmed: 10931460
Eur J Cancer. 2018 Mar;92:48-53
pubmed: 29413689
Clin Cancer Res. 2017 Jun 15;23(12):e68-e75
pubmed: 28620007
Semin Oncol. 2016 Oct;43(5):566-574
pubmed: 27899189
Am J Surg Pathol. 2014 Dec;38(12):1588-602
pubmed: 25025441
Lancet. 2013 Mar 9;381(9869):817-24
pubmed: 23312829
Pediatr Neurol. 2013 Oct;49(4):255-65
pubmed: 24053983
Lancet Oncol. 2018 Oct;19(10):1351-1359
pubmed: 30236511
Urol Clin North Am. 2012 May;39(2):133-48, v
pubmed: 22487757
Fam Cancer. 2017 Jan;16(1):123-130
pubmed: 27573198
J Urol. 2005 May;173(5):1482-6
pubmed: 15821464
J Urol. 2000 Feb;163(2):431-3
pubmed: 10647647
Clin Genitourin Cancer. 2017 Dec;15(6):652-660.e1
pubmed: 28410911
J Endocr Soc. 2017 Jun 06;1(7):897-907
pubmed: 29264540
J Urol. 2010 Apr;183(4):1309-15
pubmed: 20171681
Fam Cancer. 2014 Dec;13(4):637-44
pubmed: 25012257
J Urol. 2012 Dec;188(6):2084-8
pubmed: 23083858